565 related articles for article (PubMed ID: 22202641)
1. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer epigenetics: complex simplicity.
van Engeland M; Derks S; Smits KM; Meijer GA; Herman JG
J Clin Oncol; 2011 Apr; 29(10):1382-91. PubMed ID: 21220596
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics of colorectal cancer.
Migheli F; Migliore L
Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
[TBL] [Abstract][Full Text] [Related]
4. Folate, colorectal cancer and the involvement of DNA methylation.
Williams EA
Proc Nutr Soc; 2012 Nov; 71(4):592-7. PubMed ID: 22863281
[TBL] [Abstract][Full Text] [Related]
5. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
6. Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer.
Liu JJ; Ward RL
Adv Genet; 2010; 71():79-121. PubMed ID: 20933127
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
10. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.
Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P
J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989
[TBL] [Abstract][Full Text] [Related]
12. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of aberrant DNA methylation during colorectal cancer development.
Sakai E; Nakajima A; Kaneda A
World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
[TBL] [Abstract][Full Text] [Related]
14. One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study.
Van Guelpen B; Dahlin AM; Hultdin J; Eklöf V; Johansson I; Henriksson ML; Cullman I; Hallmans G; Palmqvist R
Cancer Causes Control; 2010 Apr; 21(4):557-66. PubMed ID: 20012180
[TBL] [Abstract][Full Text] [Related]
15. Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies.
Kim YI
Environ Mol Mutagen; 2004; 44(1):10-25. PubMed ID: 15199543
[TBL] [Abstract][Full Text] [Related]
16. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
17. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.
Suzuki H; Igarashi S; Nojima M; Maruyama R; Yamamoto E; Kai M; Akashi H; Watanabe Y; Yamamoto H; Sasaki Y; Itoh F; Imai K; Sugai T; Shen L; Issa JP; Shinomura Y; Tokino T; Toyota M
Carcinogenesis; 2010 Mar; 31(3):342-9. PubMed ID: 19638426
[TBL] [Abstract][Full Text] [Related]
18. EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers.
Karibe T; Fukui H; Sekikawa A; Shiratori K; Fujimori T
J Pathol; 2008 Sep; 216(1):32-42. PubMed ID: 18543267
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of DNA repair in breast cancer.
Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of LRRC3B in colorectal cancer.
Tian XQ; Zhang Y; Sun D; Zhao S; Xiong H; Fang J
Scand J Gastroenterol; 2009; 44(1):79-84. PubMed ID: 18815942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
